A genome-wide study of 47 registered Beefalo reveals that 39 animals, including a foundational bull sold for $2.5 million in 1975, carry no detectable bison ancestry. Researchers analyzed DNA from historical semen samples stored in a federal collection to clarify the genetic makeup of the hybrid breed.
For decades, the commercial beef industry accepted a neat narrative about Beefalo: a stable hybrid of five-eighths domestic cattle and three-eighths American bison, established through careful crossbreeding in the early 1970s. But a new genetic investigation shatters that baseline. Whole-genome sequencing of historical samples shows that the vast majority of tested animals from the founding era lack any detectable bison DNA at all.
Genomic Sequencing of Foundation Beefalo DNA
The genetic material came from straws of semen donated to the United States Department of Agriculture Agricultural Research Service National Animal Germplasm Program collection in Fort Collins, Colorado. Most of these samples were collected in the 1970s and 1980s by breeders before being transferred to the federal biobank around 2007.
The analysis yielded unexpected results. Out of 47 registered animals tested, 39 carry zero detectable bison ancestry. Among them is a famous bull named Joe’s Pride. California cattle rancher D.C. “Bud” Basolo established the breed in the early 1970s and sold Joe’s Pride to a Canadian breeder’s firm in 1975 for $2.5 million. At the time, his recorded pedigree put him at more than a third American bison. Whole-genome sequencing reveals he carries no bison DNA.
Why Early Hybridization Faced Reproductive Barriers
The discrepancy between historical pedigree records and modern genomic reality highlights the severe biological hurdles early breeders faced. Crossbreeding cattle and bison has a long history, dating back to the early 20th century. By 1942, reproductive difficulties had stopped breeders from establishing a viable hybrid population.
Bison and domestic cattle diverged approximately three million years ago. Crossing them triggers distinct genetic incompatibilities. Artificial insemination of taurine cows with bison semen frequently results in high calf mortality and sterile male offspring. Canadian government research cited in the study noted that no functional male carrying more than an eighth bison ancestry was ever observed during historical trials.
Because early breeders kept their specific pedigree methods secret, the exact lineage behind foundation animals remained an open question for fifty years. The American Beefalo Association defines the breed standard as ⅝ cattle and ⅜ bison ancestry.
- Karyotyping conducted in 1978 revealed that all 12 examined Beefalo bulls carried cattle Y chromosomes rather than bison Y chromosomes.
- Blood typing performed in 1986 on 148 animals from Basolo’s herds found that exactly one individual carried alleles predominantly associated with bison.
Indicine Genetics and Minor Bison Admixture
While 39 of the sequenced animals lacked bison ancestry entirely, the remaining eight samples told a different story. Those eight animals derive between 2 and 18 percent of their genomes from bison, placing them well short of the formal breed standard.
Instead of bison DNA, the genomic survey uncovered widespread indicine cattle ancestry among the tested Beefalo. Researchers suggest that breeding with zebu-type cattle served as an early strategy during the establishment of the breed, as indicine cattle share several phenotypic similarities with bison regarding commercially relevant traits.
The study provides the first genome-wide evaluation of the breed since the USDA granted a special roll stamp for voluntary federal inspection under 9 CFR part 352 in 1984. While current commercial herds rely primarily on breeding registered Beefalo together rather than continuous fresh backcrossing to bison, researchers emphasize that broader genomic surveys across contemporary producers remain necessary to fully map ancestry distributions across the wider population.
- Injustice 3 Seemingly Confirmed by California Playtests
- Honor Play 11 Officially Released
- Breakthrough Salk Study Uncovers Mechanism Behind Immunotherapy Resistance: Interferons, Mitochondrial Dysfunction, and PGE2″ Interferons, mitochondrial dysfunction and PGE2: Salk study reveals mechanism behind immunotherapy resistance. Boost its search engine visibility with relevant keywords for maximum impact. Immunotherapy resistance remains one of the biggest hurdles in cancer treatment. According to a recent study published in the journal Nature Communications, scientists at the Salk Institute have made a groundbreaking discovery that sheds light on the underlying mechanisms behind this resistance. The study reveals that interferons, a type of protein that plays a crucial role in the immune system, can contribute to mitochondrial dysfunction in cancer cells. This dysfunction can lead to the production of prostaglandin E2 (PGE2), a molecule that promotes tumor growth and resistance to immunotherapy. In their study, the researchers found that PGE2 production was a key factor in the development of immunotherapy resistance in cancer cells. The team used a combination of experimental and computational models to investigate the relationship between interferons, mitochondrial dysfunction, and PGE2 production. The findings of the study suggest that targeting PGE2 production could be a potential strategy for overcoming immunotherapy resistance. The researchers propose that blocking PGE2 receptors or inhibiting its production could help restore the function of mitochondria in cancer cells, making them more susceptible to immunotherapy. The study’s authors hope that their findings will pave the way for the development of new therapies that can overcome immunotherapy resistance and improve treatment outcomes for cancer patients. Key Takeaways: – Interferons contribute to mitochondrial dysfunction in cancer cells – Mitochondrial dysfunction leads to PGE2 production, promoting tumor growth and resistance to immunotherapy – Targeting PGE2 production could be a potential strategy for overcoming immunotherapy resistance – Restoring mitochondrial function in cancer cells could make them more susceptible to immunotherapy Keywords: immunotherapy resistance, interferons, mitochondrial dysfunction, PGE2, Salk Institute, cancer treatment, breakthrough study, Nature Communications. (archyworldys.com)